Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentaxonemal central apparatus

SPAG16 SPAG17

5.33e-056402GO:1990716
DomainZnf_C2H2-like

ZBTB44 ZNF613 SALL3 AKAP8 ZNF274 ZNF804B OVOL2

9.88e-04796387IPR015880
DomainZnf_C2H2

ZBTB44 ZNF613 SALL3 AKAP8 ZNF274 ZNF804B OVOL2

1.05e-03805387IPR007087
DomainZnF_C2H2

ZBTB44 ZNF613 SALL3 AKAP8 ZNF274 ZNF804B OVOL2

1.08e-03808387SM00355
DomainSNF2_N

CHD6 ATRX

1.92e-0332382PF00176
DomainSNF2_N

CHD6 ATRX

1.92e-0332382IPR000330
DomainZINC_FINGER_C2H2_2

ZBTB44 ZNF613 SALL3 ZNF274 ZNF804B OVOL2

4.44e-03775386PS50157
DomainZINC_FINGER_C2H2_1

ZBTB44 ZNF613 SALL3 ZNF274 ZNF804B OVOL2

4.50e-03777386PS00028
DomainSAM_1

SAMD3 EPHB1

8.44e-0368382PF00536
Domain-

ZBTB44 ZNF613 SALL3 ZNF274 OVOL2

1.16e-026793853.30.160.60
Pubmed

Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoB.

APOB EPHB1

1.29e-06240210705993
Pubmed

Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton.

INTS4 WWC1

7.73e-06440217010949
Pubmed

ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment.

ZNF274 ATRX

1.29e-05540227029610
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

FKBP15 KIF18A CEP76 SPAG16 ATRX MYO5B CISD1 GLRX3 PMFBP1

1.51e-05132140927173435
Pubmed

A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.

INTS4 BPTF SALL3 AKAP8

2.42e-0514640423892456
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

BPTF APOB CHD6 SPAG17 ATRX MYO5B CEP57 LYST FAM186A

3.02e-05144240935575683
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

BPTF CHD6 ATRX CSNK2A2

3.22e-0515740430186101
Pubmed

Crisp1 and alopecia areata in C3H/HeJ mice.

LYST SGK3

3.60e-05840225446841
Pubmed

Analysis of the sperm flagellar axoneme using gene-modified mice.

SPAG16 SPAG17

3.60e-05840232554934
Pubmed

Differentiating inbred mouse strains from each other and those with single gene mutations using hair proteomics.

LYST SGK3

3.60e-05840223251662
Pubmed

Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.

INTS4 ZBTB44 CEP76 SAMD3 ARFIP2 CEP57 GLRX3 BCAS2 CSNK2A2

3.64e-05147740931515488
Pubmed

An Oct4-centered protein interaction network in embryonic stem cells.

BPTF FKBP15 SALL3 AKAP8

4.10e-0516740420362541
Pubmed

Embryonic signaling centers expressing BMP, WNT and FGF proteins interact to pattern the cerebral cortex.

FGF8 EPHB1

4.62e-05940215509764
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

BPTF APOB CHD6 FAM186A BBS10

1.17e-0442040528065597
Pubmed

Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci.

LYST SGK3

1.34e-04154026696991
Pubmed

The mouse Ovol2 gene is required for cranial neural tube development.

FGF8 OVOL2

1.53e-041640216423343
Pubmed

Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities.

FGF8 SALL3

1.73e-041740219168674
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

INTS4 BPTF CHD6 ATRX CSNK2A2

1.95e-0446940527634302
Pubmed

Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesis.

FGF8 ATRX

1.95e-041840214645126
Pubmed

Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.

KIF18A RASSF9 CSNK2A2 WWC1

2.61e-0427040424366813
Pubmed

Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway required for cardiac inflow tract development.

FGF8 SALL3

3.21e-042340220159597
Pubmed

TBX3 is essential for establishment of the posterior boundary of anterior genes and upregulation of posterior genes together with HAND2 during the onset of limb bud development.

FGF8 SALL3

3.21e-042340238828908
Pubmed

Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.

BPTF TRANK1 CSNK2A2

3.26e-0411640321282530
Pubmed

Otx2 and Otx1 protect diencephalon and mesencephalon from caudalization into metencephalon during early brain regionalization.

FGF8 EPHB1

3.50e-042440220816794
Pubmed

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

INTS4 FKBP15 AKAP8 CSNK2A2

3.79e-0429840432353859
Pubmed

Proteomic characterization of the human centrosome by protein correlation profiling.

CEP76 CEP57

4.12e-042640214654843
Pubmed

Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling.

FGF8 EPHB1

4.12e-042640235927240
Pubmed

Emx1 and Emx2 cooperate in initial phase of archipallium development.

FGF8 EPHB1

4.78e-042840215147765
Pubmed

Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo.

FGF8 APOB

4.78e-042840216109169
Pubmed

Emx2 and Pax6 function in cooperation with Otx2 and Otx1 to develop caudal forebrain primordium that includes future archipallium.

FGF8 EPHB1

4.78e-042840215917450
Pubmed

TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment.

APOB ATRX CSNK2A2

5.42e-0413840337506885
Pubmed

Functional proteomics mapping of a human signaling pathway.

KIF18A ZBTB44 CHD6 ATRX GLRX3

5.61e-0459140515231748
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

FKBP15 ATRX CISD1 LYST CSNK2A2 SGK3

5.67e-0491040636736316
Pubmed

Genetic associations of brain structural networks in schizophrenia: a preliminary study.

APOB WWC1

5.87e-043140220691427
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

INTS4 BPTF ZBTB44 CHD6 AKAP8 ATRX BCAS2

6.17e-04129440730804502
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

FKBP15 AKAP8 BCAS2 CSNK2A2

6.21e-0434040424332808
Pubmed

Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.

BPTF FGF8

8.83e-043840218974875
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

BPTF FKBP15 ATRX GLRX3 BCAS2 CSNK2A2

9.95e-04101440632416067
Pubmed

OTX2 Transcription Factor Controls Regional Patterning within the Medial Ganglionic Eminence and Regional Identity of the Septum.

FGF8 SALL3

1.08e-034240226166575
Pubmed

Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.

BPTF AKAP8 ATRX

1.11e-0317740326206133
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

FKBP15 KIF18A WWC1

2.98e-03181293694
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZBTB44 ZNF613 SALL3 ZNF274 OVOL2

5.24e-0371829528
GeneFamilySterile alpha motif domain containing

SAMD3 EPHB1

8.73e-0388292760
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500

KIF18A FGF8 APLP1 CEP76 SALL3 ATRX WWC1

3.00e-05498397Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlasratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_1000

KIF18A FGF8 CEP76 ZNF613 SALL3 NEK11 PMFBP1 BBS10 OVOL2

5.68e-05983399PCBC_ratio_EB-blastocyst_vs_EB-fibro_1000
ToppCellE17.5-Epithelial-airway_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RASSF9 SPAG16 FAM13A SPAG17 CISD1

6.18e-0718340507cebb0e186e1bff14ac2a6bb6f8412d4aaa2350
ToppCellE17.5-Epithelial-airway_epithelial_cell-club_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RASSF9 SPAG16 FAM13A SPAG17 CISD1

6.18e-07183405e8e85e5be909f9cd85a6a041190bfcb855dfa1a4
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1 OVOL2

2.11e-05182404cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1 OVOL2

2.16e-05183404ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1 OVOL2

2.21e-05184404cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1 OVOL2

2.21e-051844047cc5796557379c3d1db078c1aeda40659c6e401c
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1 OVOL2

2.25e-051854043bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 FAM13A MYO5B WWC1

2.30e-051864044e94158db52df41d71e67b02b9895a358eebee0f
ToppCellLPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1 OVOL2

2.35e-05187404201ff693e4756ee3e44762885b3a303a77eb535b
ToppCellLPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1 OVOL2

2.40e-051884046164d467b612767ceba15de34176bcc8e8c36ab8
ToppCellCOVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type

SPAG16 SPAG17 TRPV5 WWC1

2.40e-051884048f9996c3f3b27efaaae8960a66af77412de9c7ef
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1 OVOL2

2.45e-051894045f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCellfacs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FAM13A MYO5B WWC1 ZNF804B

2.66e-05193404c5925b3b5d19098e3987789d68a493d7fd548ac9
ToppCellfacs-Trachea-3m-Epithelial-glandular_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FAM13A MYO5B WWC1 ZNF804B

2.66e-051934046905de261d90dfe3dd2c2cf5b2e26afb2bcc3d5b
ToppCellfacs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FAM13A MYO5B WWC1 ZNF804B

2.66e-05193404f73630725f093c646bdaf178c39505c04a16e2c6
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

RASSF9 MYO5B WWC1 ZNF804B

2.71e-05194404f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPAG16 SPAG17 MYO5B WWC1

2.71e-0519440493c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CHD6 FAM13A MYO5B OVOL2

2.82e-05196404547901c7a665770eff78eede69b8625b416c8186
ToppCellIPF-Epithelial|IPF / Disease state, Lineage and Cell class

SPAG16 SPAG17 MYO5B WWC1

2.82e-0519640487d9881cfec461a5d89b688a83749b618c519485
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CHD6 FAM13A MYO5B OVOL2

2.82e-051964046e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b
ToppCellCaecum-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass

AKAP8 ARFIP2 FAM186A PMFBP1

2.88e-0519740440c8ff067e8242e2ca083ea04cd6026168191a97
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

NEK11 PMFBP1 OVOL2

1.50e-04115403207d464c09caf9be361daa56c83cd7da5cf9ce47
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SAMD3 MYO5B EPHB1

1.96e-041264039b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1

2.15e-041304036434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF613 SALL3 TRPV5

2.41e-0413540352b5c664c0b7a303c6084d508748dcb6c38a0c23
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FGF8 SALL3 TRPV5

2.85e-04143403990844ca674d30b2924c74b45bed4fdfb8463fa7
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KIF18A CEP76 EPHB1

2.91e-04144403b638398f559e7fd9d4294d1c830beeb20f905960
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

MYO5B PMFBP1 EPHB1

3.34e-04151403f50c5ae9dae507df750df25e151b58685fec70ce
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FGF8 APLP1 SAMD3

3.41e-041524030652ee3443e6fbb679d2c4f326239ae7c803f924
ToppCellLPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

3.47e-04153403e7a074ea8232bacf924be78a244a8507c7e1ebc8
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B OVOL2

4.03e-041614031e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCellPND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASSF9 FAM13A CISD1

4.03e-0416140341a89a3d99a9bd6039a3d881d1d9dcd18bc07f25
ToppCellPND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASSF9 FAM13A CISD1

4.03e-04161403c4970501c038ed36de447da70eabff020ad78713
ToppCellBAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters

SPAG16 NEK11 EPHB1

4.03e-041614037a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCellLPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 SPAG17 OVOL2

4.41e-04166403eb942ed68677e55c46cb039046f45686d4062d7c
ToppCellLPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 WWC1 OVOL2

4.41e-041664031df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d
ToppCellLPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 WWC1 OVOL2

4.41e-041664039628522e7af8f8edca733588a364ab2454ac5ca5
ToppCell367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells)

APOB RASSF9 BBS10

4.56e-04168403b8c65542a0701ae31f49d332d87a64578e24b4e3
ToppCell367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells)

APOB RASSF9 BBS10

4.56e-041684038c95093b1ea45826f62893edd3c410fe53b563a4
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 SPAG17 OVOL2

4.64e-0416940386041be5d3aeab5b9269f7912791b944f325a1b4
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 SPAG17 OVOL2

4.64e-041694038c96e1baa38ec5e777e627ab9dbce025e771f2c0
ToppCelldroplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASSF9 NEK11 OVOL2

4.64e-0416940330141f76e9bfc2b4586429857c72dbc85ba65cc9
ToppCellE16.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASSF9 FAM13A WWC1

4.64e-0416940308ac28c5ad8f5c5f9f54af341bf39e8f9417636e
ToppCellE16.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASSF9 FAM13A WWC1

4.64e-04169403e5abd41db1e6724ad900e37658fa063b8e522908
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APLP1 APOB MYO5B

4.81e-041714035d0d6c1ff610a703ae0b834a12823c5ff9012932
ToppCell367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells)

APOB MYO5B WWC1

5.06e-04174403edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e
ToppCell367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells)

APOB MYO5B WWC1

5.06e-0417440365539f69100db0b7d90b1b39ee15ab8281f86461
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPAG17 NEK11 WWC1

5.14e-04175403284fdc7a9d303636a637041846850d19d114861a
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TRANK1 MYO5B CEP57

5.14e-04175403bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TAS2R4 FAM13A LYST

5.23e-0417640376fdf211bce101e83a27d822cb399487bd107027
ToppCellFF-Differ-KC|World / shred by cell class for mouse tongue

RASSF9 MYO5B PMFBP1

5.49e-041794031526a130565a97c291a25a7a988089bffc1515c1
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAM13A MYO5B WWC1

5.49e-04179403fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1

5.67e-04181403b45b11428d13950369347e051d4d517efb2bd4fd
ToppCellControl-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

5.76e-04182403a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCelldroplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD3 ATRX LYST

5.76e-041824031710eab3037a87609d21838be2d2d29c3bc36651
ToppCellTCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod|TCGA-Mesothelium / Sample_Type by Project: Shred V9

ZBTB44 TRANK1 MYO5B

5.76e-04182403bb1f815718397de96682697fcbd6014a992a28f7
ToppCelldroplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAMD3 ATRX LYST

5.76e-04182403e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

5.85e-0418340306ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B OVOL2

5.85e-04183403274483009b309289e4cb84beedf6806430db6ff6
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APOB TRANK1 SPAG17

5.95e-04184403ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellE12.5-Epithelial-airway_epithelial_cell-club_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RASSF9 FAM13A OVOL2

5.95e-04184403a69c3c57cd939b2888f548a0fbca3392ad310445
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APOB TRANK1 SPAG17

5.95e-041844032cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APOB TRANK1 SPAG17

5.95e-041844032b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 MYO5B WWC1

5.95e-0418440342ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCellPND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM13A CISD1 WWC1

5.95e-0418440341164109d9d7bb1c431220e2e85e08dc5f56856d
ToppCellE12.5-Epithelial-airway_epithelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RASSF9 FAM13A OVOL2

5.95e-041844033df78b17098b50e1a7f2c8791bf2d0806328330a
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAM13A MYO5B WWC1

5.95e-04184403ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAM13A MYO5B WWC1

6.04e-04185403fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCellLPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

6.04e-041854030c247a3f394c42e2a6f67fee3d9cf33096fecd13
ToppCellLPS_only-Epithelial_alveolar-AT_1-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

6.04e-0418540368f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCellControl-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

6.04e-041854033937e026add96a396122139daf8011cfbc60e75c
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

6.04e-04185403c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCellP28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPAG16 SPAG17 NEK11

6.14e-04186403a26811481668fa25c48a064a56c198685693ad8d
ToppCellP28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPAG16 SPAG17 NEK11

6.14e-04186403df80f101954b8ec6ccdb03e702de22e70b65181f
ToppCellControl-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RASSF9 LYST EPHB1

6.14e-0418640392092f11ecce22c14f244e42c499af0822977e6f
ToppCellCOPD-Epithelial-Club|World / Disease state, Lineage and Cell class

RASSF9 MYO5B WWC1

6.14e-041864033006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCellLPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

6.23e-04187403ff26a533d310126521efe1d05cf8b9d32e524550
ToppCellPCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

RASSF9 MYO5B WWC1

6.23e-04187403c2940aec30b3c2c113f6a65126dc6f1969cf301e
ToppCellP15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPAG16 SPAG17 NEK11

6.23e-04187403a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAM13A MYO5B WWC1

6.33e-041884034bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellE18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASSF9 FAM13A CISD1

6.33e-04188403176a207dde6dd122a11e6c67c6299bc5179ff049
ToppCellE18.5-Epithelial-Epithelial_Airway-Neurosecretory|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASSF9 FAM13A CISD1

6.33e-04188403a6cbe58c5029acefbfbb64c3bff570de4e5e2449
ToppCellE18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RASSF9 FAM13A CISD1

6.33e-041884036fb37e3b139955e6ee6be26ab6cd3ce85d765ca6
ToppCellP15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPAG16 SPAG17 NEK11

6.33e-04188403e3e71c0f2e374330620cb4d27638953ffa9f5298
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO5B WWC1 OVOL2

6.33e-0418840343a0508d2524a5b310e89e9422843dcaab999bc3
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MYO5B WWC1 ZNF804B

6.43e-041894037659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCellCOPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

SPAG16 SPAG17 NEK11

6.43e-041894033e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCellfacs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SPAG16 SPAG17 NEK11

6.53e-041904039ffd18ef358f8e32c610ab6420f479067c8ba44b
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MYO5B WWC1 ZNF804B

6.53e-04190403c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCellfacs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SPAG16 SPAG17 NEK11

6.53e-041904033ef39d61c98de4e5df946b995847aa65eba6a4b6
ToppCellE18.5-Epithelial-Epithelial_Airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM13A SPAG17 CISD1

6.53e-041904035c012935ea5e35a2d0d08ea7dc04ffbe3c2a10ac
ToppCellfacs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPAG16 SPAG17 NEK11

6.53e-04190403e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1
ToppCellfacs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPAG16 SPAG17 NEK11

6.53e-04190403fe844559b95832845d2e8d3ab4b57e3d558bc372
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPAG17 NEK11 WWC1

6.53e-041904033fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCellfacs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SPAG16 SPAG17 NEK11

6.63e-04191403649fcb62ad15de2f83e61591e43923a717664ae7
ToppCellASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

SPAG16 SPAG17 NEK11

6.63e-041914030c4b926a28bc94f3cf4d68a911c0a189f6ff505e
ToppCellfacs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SPAG16 SPAG17 NEK11

6.63e-041914039621e22e14ea069f22713947c9faa2d882abe5fe
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SPAG16 SPAG17 NEK11

6.63e-04191403e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCellCOPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class

RASSF9 MYO5B WWC1

6.63e-04191403c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

RASSF9 MYO5B ZNF804B

6.63e-0419140360ff989fe99d243a3d52955223680cdd1f1917a4
Disease4-vinylphenol sulfate measurement

SGK3 EPHB1

6.84e-0510372EFO_0021149
Diseasemale infertility (implicated_via_orthology)

CSNK2A2 PMFBP1

1.18e-0413372DOID:12336 (implicated_via_orthology)
Diseasecarotid artery intima media thickness

APOB SAMD3 RASSF9 FAM13A NEK11

2.35e-04450375EFO_0007117
Diseasetriglyceride measurement, intermediate density lipoprotein measurement

BPTF APOB PMFBP1

3.67e-04111373EFO_0004530, EFO_0008595
Diseasecholesterol:total lipids ratio, high density lipoprotein cholesterol measurement

BPTF APOB FAM13A PMFBP1

3.88e-04276374EFO_0004612, EFO_0020943
Diseaseapolipoprotein A 1 measurement

APOB TRANK1 FAM13A MYO5B CSNK2A2 PMFBP1

6.01e-04848376EFO_0004614
Diseasetriglyceride measurement, phospholipid measurement

BPTF APOB PMFBP1

8.15e-04146373EFO_0004530, EFO_0004639
Diseaseage at onset, Myopia

FAM13A MYO5B SGK3

8.81e-04150373EFO_0004847, HP_0000545
Diseaseserum gamma-glutamyl transferase measurement

BPTF TRANK1 ATRX CSNK2A2 PMFBP1 EPHB1

8.89e-04914376EFO_0004532
DiseaseCraniofacial Abnormalities

FGF8 SALL3 ATRX

9.87e-04156373C0376634
Diseasehigh density lipoprotein particle size measurement

APOB FAM13A MYO5B

1.26e-03170373EFO_0008592
DiseaseNeuroblastoma

CHD6 ATRX

1.60e-0347372C0027819
Diseasephospholipids in very small VLDL measurement

APOB PMFBP1

1.88e-0351372EFO_0022300
Diseaseinterleukin 1 receptor antagonist measurement

TRANK1 SPAG16

2.03e-0353372EFO_0004754
Diseasecholesterol to total lipids in large HDL percentage

APOB FAM13A

2.18e-0355372EFO_0022234
Diseasetriglycerides:total lipids ratio, high density lipoprotein cholesterol measurement

BPTF APOB FAM13A

2.19e-03206373EFO_0004612, EFO_0020947
Diseasetriglycerides in LDL measurement

BPTF APOB

2.26e-0356372EFO_0022320
Diseasefree cholesterol measurement, very low density lipoprotein cholesterol measurement

BPTF APOB PMFBP1

2.47e-03215373EFO_0008317, EFO_0008591

Protein segments in the cluster

PeptideGeneStartEntry
HVAKSVLNNRHIVKM

AKAP8

521

O43823
KAQQMRFQVHTHLQV

APLP1

441

P51693
HAVVANVQLVLHLMK

CEP57

301

Q86XR8
NVQLVLHLMKQHSKA

CEP57

306

Q86XR8
IKVMHKQLLLFHNAV

ARFIP2

291

P53365
LKQLIHQQLSKMDVH

CEP76

11

Q8TAP6
VVMKHNAVIEHLKQK

BPTF

2666

Q12830
AIMKHLHSQNVKLLI

BBS10

296

Q8TAM1
ISQDHTIHQQVKRMK

RASSF9

191

O75901
NKQVVIIHHMRLQAK

INTS4

716

Q96HW7
IIHHMRLQAKALQLI

INTS4

721

Q96HW7
HQKKILNSIHSMRVQ

EPHB1

961

P54762
VNKLKREMVHLQHEL

WWC1

171

Q8IX03
FSKQMVEILHKHNIQ

GLRX3

161

O76003
LHLQNKDLKAQIRHM

KIF18A

541

Q8NI77
QVSHLQLKMTAHQKK

FKBP15

651

Q5T1M5
HIINAMQKRIHLQTL

NEK11

316

Q8NG66
QRMLNRHLKCHNQVK

OVOL2

131

Q9BRP0
TKVAKHHVQNRMNVH

FAM13A

176

O94988
KHVQVLANKRINAMA

FGF8

81

P55075
VRVTQEFHMKVKHLI

APOB

4176

P04114
QVHRNMVIKLKPHQV

ATRX

1551

P46100
HLKQHCNKVLLRVRM

CHD6

1221

Q8TD26
HNVMIDHQQKKLRLI

CSNK2A2

161

P19784
MFNIKQLLKAQVVHH

LYST

1951

Q99698
MIHVFNQLKKIHELN

FAM186A

2226

A6NE01
KKFTNAVVLQQHIRM

SALL3

746

Q9BXA9
HIMAERNVLLKNVKH

SGK3

206

Q96BR1
HSVMVHLQQENKKLK

PMFBP1

926

Q8TBY8
RMVQQLVKKIGHQAV

SAMD3

41

Q8N6K7
NLVHMIEHAQKELQK

BCAS2

141

O75934
KVRVVKDNHNFMIHL

SPAG17

1061

Q6Q759
VKDHRNKAMINLHIQ

CISD1

36

Q9NZ45
QQHMQKQLLSKHLRV

ZNF804B

1166

A4D1E1
QVKSMKHNSRVKIHQ

ZNF274

456

Q96GC6
RMHHKRIVQEKNKLI

SPAG16

196

Q8N0X2
IQNLKQHMLIHSGIK

ZBTB44

411

Q8NCP5
KKVDNHLQMHSQKQR

ZNF613

81

Q6PF04
HLQMHSQKQRCLKRV

ZNF613

86

Q6PF04
SHMLQKVQEHIKRVS

TRANK1

2831

O15050
QHLDKLHMLQQKRIL

TRPV5

31

Q9NQA5
HSLRRHIQKMQKNAT

TAS2R4

201

Q9NYW5
RQVLMEHKATTIQKH

MYO5B

856

Q9ULV0